|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone(Follistim*/Puregon)in healthy female volunteers显示文摘 | Voortman G Mannaerts BM Huisman JA | 2000 | Fertil Steril2000，73，： | 1 |
| 2 | A randomized three- way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin ( Pregnyl ) after intramuscular and subcutaneous administration显示文摘 | Mannaerts BM Geurts TB Odink J | 1998 | Hum Reprod1998，13，6： | 1 |
| 3 | A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration 显示文摘 | Mannaerts BM Geurts TB Odink J | 1998 | Hum Reprod1998，13，6： | 1 |
| 4 | A prospective, randomized, assessor - blind, multicentre study comparing recombinant and urinary follicle stimulating hormone ( Puregon versus Metrodin) in in-vitro fertilization 显示文摘 | Out HJ Mannaerts BM Driessen SG | 1995 | Hum Reprod1995，10，10： | 1 |
| 5 | Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency 显示文摘 | FAUSER BC MANNAERTS BM DEVROEY P | 2009 | Hum Reprod Update2009，15，3： | 1 |
| 6 | Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency显示文摘 | Fauser BC Mannaerts BM Devroey P | 2009 | Hum Reprod Update2009，15，3： | 1 |
| 7 | Advances in recombinant DNA technology: corifollitropin alfa,a hybrid molecule with sustained follicle stimulating activity and reduced injection frequency显示文摘 | Fauser BC Mannaerts BM Devroey P | 2009 | Hum Reprod Update2009，15，3： | 1 |
| 8 | A prospective,randomized,assessor-blind,multicentre study comparing recombinant and urinary follicle stimulating hormone(Puregon versus Metrodin)in in-vitro fertilization显示文摘 | Out HJ Mannaerts BM Driessen SG | 1995 | Hum Reprod1995，10，10： | 1 |
| 9 | Obstetrical and neonatal outcome after controlled ovarian stimulation for IVF using the GnRH antagonist ganirelix 显示文摘 | Boerriger PJ de Bie JJ Mannaerts BM | 2002 | Hum Reprod2002，17，8： | 1 |
| 10 | Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH 显示文摘 | Tarlatzis BC Griesinger G Leader A Rombauts L Ijzerman Boon PC Mannaerts BM | 2012 | Reprod Biomed Online2012，24，4： | 1 |
| 11 | Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency 显示文摘 | Fauser BC Mannaerts BM Devroey E | 2009 | Hum Reprod Update2009，，： | 1 |
| 12 | Advances in recombinant DNA technology: corifollitropinalfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency 显示文摘 | Fauser BC Mannaerts BM Devroey P | 2009 | Hum Reprod Update2009，15，3： | 1 |
| 13 | Recombinant follicle-stimulating hormone(follitropin beta,Puregon)yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins显示文摘 | Out HJ Driessen SG Mannaerts BM | 1997 | Fertil Steril1997，68，1： | 1 |
| 14 | Clinical profiling of recombinant follicle stimulating hormone ( rFSH Puregon) :relationship between serum FSH and efficacy显示文摘 | Mannaerts BM Rombout F Out H J | 1996 | Hum Reprod Update1996，2，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员